PCSK9 inhibitors and LDL reduction: pharmacology, clinical implications, and future perspectives

Gerald Fitzgerald, Tom Kiernan

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'PCSK9 inhibitors and LDL reduction: pharmacology, clinical implications, and future perspectives'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science